UPDATE 2-Honeybee homicide case against Syngenta pesticide unproven

* British study says earlier research flawed

* Previous research led to French ban on pesticide

* Pesticide maker Syngenta says new study backs its argument

* Environmentalists say doubts remain about impact on bees

(Adds comment from Syngenta and Friends of the Earth)

LONDON, Sept 21 (Reuters) - British scientists have shot

down a study on declining honeybee populations that triggered a

French ban on a pesticide made by Swiss agrochemicals group

Syngenta.

France's farm minister Stephane Le Foll withdrew Syngenta's

marketing permit for the pesticide Cruiser OSR in

June, citing evidence of a threat to the country's bees.

But a study by Britain's Food and Environment Research

Agency with the University of Exeter says the results of the

original research were flawed.

The study, published in the journal Science, does not deny

that pesticides could be harmful to individual bees but argues

there is no evidence they cause the collapse of whole colonies.

"We do not yet have definitive evidence of the impact of

these insecticides on honeybees and we should not be making any

decisions on changes to policy on their use," said James

Cresswell, the ecotoxicologist who led the latest study.

The previous research, led by French scientist Mikaël Henry

and published in Science in April, showed the death rate of bees

increased when they drank nectar laced with the neonicotinoid

pesticide, thiamethoxam, the active ingredient in Cruiser OSR.

Neonicotinoids are among the most widely-used agricultural

insecticides.

Henry's work calculated this would cause a bee colony to

collapse completely but Cresswell said the French study seemed

to have used an inappropriately low birth rate, underestimating

the rate at which colonies can recover from the loss of bees.

"They modelled a colony that isn't increasing in size and

what we know is that in springtime when oilseed rape is

blossoming they increase rapidly," Cresswell told Reuters.

The French study has been cited by scientists,

environmentalists and policy-makers as evidence of the impact of

these pesticides on bees, which are declining around the world.

"We know that neonicotinoids affect honeybees, but there is

no evidence that they could cause colony collapse," said

Cresswell. "When we repeated the previous calculation with a

realistic birth rate, the risk of colony collapse under

pesticide exposure disappeared."

DOSAGE DOUBTS

Cresswell said Henry's research also used a dosage of

pesticide equivalent to a whole day's intake by the bees, akin

to testing the effect of coffee on people by making them drink

eight cups in one go, rather than spread out over the day.

Henry said he was "perfectly comfortable" with the new

findings, adding in an emailed response to Reuters: "The model

we used predicts a major deviation from the expected colony

dynamics, rather than a collapse per se."

The April paper in Science said exposure to thiamethoxam

"causes high mortality due to homing failure at levels that

could put a colony at risk of collapse".

Syngenta lost a court bid in July to overturn the French ban

on Cruiser OSR, which meant the pesticide was not used for

rapeseed sowing in August and September.

"It's important for us that what we had argued is now

supported by a scientific study," Syngenta France spokesman

Laurent Peron told Reuters. "We are going to use the findings of

this study but it's too early to say in what way."

The French farm ministry declined to comment.

Environmental campaign group Friends of the Earth argued

that sales of the pesticide should be halted while any doubt

about their impact on bees remained.

"Neonicotinoid pesticides cannot be given a clean bill of

health until they have been properly tested for their effect on

all bees, not just honeybees," said campaigner Paul de Zylva.

Cresswell said: "I am definitely not saying that pesticides

are harmless to honeybees, but I think everyone wants to make

decisions based on sound evidence, and our research shows that

the effects of thiamethoxam are not as severe as first thought."

(Additional reporting by Gus Trompiz in Paris; Editing by

Belinda Goldsmith and Pravin Char)